Lotus Pharm vs CHBIO: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and CHBIO (6534) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ CHBIO

0%+226%-33%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYCHBIOYoY
Oct 2026NT$2.13 billion-22.5%NT$62 million-26.4%
Sep 2026NT$2.77 billion+128.0%NT$118.3 million+11.5%
Aug 2026NT$2.11 billion+81.7%NT$39.9 million-33.4%
Jul 2026NT$2.49 billion+3.9%NT$62.2 million+22.7%
Jun 2026NT$3.4 billion+225.5%NT$88.9 million+28.6%
May 2026NT$2.32 billion+105.8%NT$141.4 million+7.3%
Apr 2026NT$3.09 billion+19.9%NT$229.2 million+4.4%
Mar 2026NT$4.35 billion+173.6%NT$377.3 million+2.5%
Feb 2026NT$2.24 billion+131.5%NT$272.9 million+2.1%
Jan 2026NT$2.05 billion-5.5%NT$219.3 million+0.6%
Dec 2025NT$2.44 billion+66.9%NT$153 million+13.7%
Nov 2025NT$1.06 billion-0.2%NT$91.2 million+32.4%
Oct 2025NT$2.75 billion+46.0%NT$84.2 million+17.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16